Two doses of AstraZeneca and Pfizer-BioNTech vaccines provided much lower levels of protection against symptomatic infection compared to what they provide against delta, the UK Health Security Agency said.
Regardless of the initial vaccine a patient received, a Pfizer-BioNtech booster provided 70% – 75% protection against symptomatic infection for people.
Booster Covid-19 vaccine shots give an estimated 70% to 75% protection against mild disease from the new omicron variant, the UK Health Security Agency said on Friday, citing initial findings from a real-world study.
The findings are some of the earliest data on the protection against omicron outside of lab studies, which have shown reduced neutralizing activity against omicron.
The early real-world data suggest that while omicron could greatly reduce the protection against mild disease from an initial two-dose vaccination course, boosters restored the protection to an extent.
“These early estimates should be treated with caution but they indicate that a few months after the second jab, there is a greater risk of catching the omicron variant compared to delta strain,” said Dr. Mary Ramsay, Head of Immunization at the UKHSA, adding that protection against severe disease was expected to remain higher.
“The data suggest this risk is significantly reduced following a booster vaccine, so I urge everyone to take up their booster when eligible.”
In an analysis of 581 people with confirmed omicron, two doses of AstraZeneca and Pfizer-BioNTech, vaccines provided much lower levels of protection against symptomatic infection compared to what they provide against delta.
However, when boosted with a dose of Pfizer vaccine, there was around 70% protection against symptomatic infection for people who initially received AstraZeneca, and around 75% protection for those who received Pfizer.
That compares to estimated protection against infection from Delta following a booster of around 90%.
UKHSA said that, at current trends, omicron would account for more than 50% of all Covid-19 infections by mid-December, with Britain exceeding one million infections by the end of the month.
Sources from: CNBC
SVE NEWS is the leader in world news liberal sharing.
(Comments on this news are welcome)
2021 CWMALLS: Standard, Sharing,Ecology, Value;
2021 CWMALLS COMMODITY: Patent, Technology, Art, Intelligence;
2021 CWMALLS NEW SPECIES: Keen, Aggressive, Personality, Value;
2021 MWE FUND: Charity, Public Welfare, Responsibility
Tips: In order to explore more planet species diversity and ecosystem of Mars and earth’s biosphere of cohesion, from now on in the chosen experts and scholars of Mars and planets, especially the astrophysicist, astrobiologists, astrochemists, and so on all over the world’s elite, contribute to the existence and development of simulation of Mars landing. Thank you very much! CWS (Mars) Asia-Pacific Preparatory Committee 0086-57189877088/89877099 E-mail: email@example.com October 3, 2021 M1073 E2021